Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension and single nucleotide polymorphisms.

M J Rieder1, D A Nickerson

  • 1Department of Molecular Biotechnology, University of Washington, Box 357730, Seattle, WA 98115, USA.

Current Hypertension Reports
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex/gender differences in clinical pharmacology: A perspective from the IUPHAR World Smart Medication Day 2025.

Pharmacological research·2025
Same author

Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model.

Diagnostic and interventional imaging·2020
Same author

A homozygous missense mutation in SLC25A16 associated with autosomal recessive isolated fingernail dysplasia in a Pakistani family.

The British journal of dermatology·2017
Same author

Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics.

Clinical pharmacology and therapeutics·2017
Same author

An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings.

Clinical pharmacology and therapeutics·2016
Same author

Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner.

The pharmacogenomics journal·2016
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Identifying genetic factors for hypertension involves studying candidate genes and their variations. Research shows single nucleotide polymorphisms (SNPs) in genes like angiotensin-converting enzyme (ACE) are complex and crucial for understanding hypertension susceptibility.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Human Population Genetics

Background:

  • Hypertension is a complex disease with significant genetic influences.
  • Identifying genetic susceptibility loci is crucial for understanding disease mechanisms.
  • The renin-angiotensin system (RAS) is a key pathway in blood pressure regulation.

Purpose of the Study:

  • To explore the genetic basis of hypertension.
  • To investigate the role of candidate genes and sequence variants in hypertension susceptibility.
  • To examine the complexity of single nucleotide polymorphisms (SNPs) in human populations.

Main Methods:

  • Genetic analysis in model organisms.
  • Linkage analysis in families and sib-pairs.

Related Experiment Videos

  • Association studies using sequence variants in candidate genes.
  • Exploration of sequence diversity and SNP distribution.

    • Main Results:

    • Candidate genes for hypertension are continuously being identified.
    • The distribution and organization of SNPs are complex across human populations.
    • Studies on angiotensin-converting enzyme (ACE) illustrate challenges in using SNPs for hypertension genetics.

    Conclusions:

    • Genetic factors play a significant role in hypertension development.
    • Understanding SNP complexity is vital for genetic association studies.
    • Further research is needed to fully elucidate the genetic determinants of hypertension.